Aldosterone Renin Ratio (ARR) Test to Increase Case-detection of Primary Aldosteronism (PA)
NCT05757076 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53
Last updated 2026-02-23
Summary
The mission of this project is to increase the detection of Primary Aldosteronism (PA), the most common cause of secondary hypertension, which can either be cured surgically or treated with targeted medications.
Conditions
- Primary Aldosteronism
Interventions
- PROCEDURE
-
Blood test for ARR
Blood test for calculating aldosterone and renin ratio (ARR)
Sponsors & Collaborators
-
The Cleveland Clinic
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-05-02
- Primary Completion
- 2025-08-01
- Completion
- 2025-12-29
Countries
- United States
Study Locations
More Related Trials
-
Steroids-Based Screening for Primary Aldosteronism
NCT06941116 ·Status: RECRUITING
-
Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease
NCT06190158 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Primary Aldosteronism in General Practice: Organ Damage, Epidemiology and Treatment
NCT01728493 ·Status: COMPLETED
-
The Plasma Metabolomics Profiling of Primary Aldosteronism
NCT06500000 ·Status: COMPLETED
-
Multi-omics Studies of Primary Aldosteronism
NCT07111351 ·Status: RECRUITING
-
Adrenal Artery Ablation for Primary Aldosteronism
NCT03653845 ·Status: UNKNOWN ·Phase: PHASE3
-
Diagnosis of Primary Aldosteronism: Comparison of Post Captopril Active Renin Concentration and Plasma Renin Activity
NCT00917345 ·Status: UNKNOWN
-
The Diagnostic Performance of 24-hour Urinary Aldosterone for Primary Aldosteronism
NCT06236698 ·Status: COMPLETED
-
Diagnostic Accuracy of Seated Saline Suppression Test for Primary Aldosteronism
NCT03500120 ·Status: COMPLETED
-
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
NCT00920764 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism
NCT03174847 ·Status: COMPLETED
-
Aldosterone and Vascular Disease in Diabetes Mellitus
NCT00214825 ·Status: COMPLETED ·Phase: NA
-
Trial of Aldosterone-hybrid SteRoid for Guiding curablE Treatment of Primary Aldosteronism (TARGET-PA)
NCT07297745 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Untargeted Metabolomics for Primary Aldosteronism
NCT06076473 ·Status: RECRUITING
-
Adrenal Artery Ablation Treats Primary Aldosteronism
NCT03398785 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Adrenal Artery Ablation and Spironolactone in Patients With Primary Aldosteronism
NCT04409431 ·Status: RECRUITING ·Phase: NA
-
Statin Combined with Amlodipine Treats Primary Aldosteronism
NCT06523465 ·Status: RECRUITING ·Phase: PHASE4
-
Aldosterone Blockade in Chronic Kidney Disease: Influence on Arterial Stiffness and Kidney Function
NCT01100203 ·Status: TERMINATED ·Phase: PHASE3
-
Prospective Phenotyping of Autonomous Aldosterone Secretion
NCT03484130 ·Status: ACTIVE_NOT_RECRUITING
-
REnin-guided TherApy With MinEralocorticoid Receptor Antagonists in Primary Aldosteronism - Feasibility Study
NCT06108427 ·Status: RECRUITING ·Phase: NA
-
Postoperative Cardiovascular Index Change of Primary Aldosteronism
NCT00746070 ·Status: UNKNOWN
-
Simplification of Oral Sodium Loading Test in the Diagnosis of Primary Aldosteronism: 2-day Replacing 3-day Method
NCT06750172 ·Status: RECRUITING
-
Pilot Study of Aprepitant Effect on Aldosterone Secretion in Diabetic Patient (Diabetes Mellitus) With Hypertension Associated With Low Renin
NCT02811055 ·Status: COMPLETED ·Phase: PHASE2
-
Inhibition of Aldosterone in Patients With Chronic Renal Disease
NCT00430924 ·Status: COMPLETED ·Phase: PHASE4
-
Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing
NCT07281014 ·Status: RECRUITING ·Phase: PHASE4